OCT — Clinical Trials in Russia, Central and Eastern Europe

OCT Business Development team is attending this event. Please contact them at jnedokusheva@oct-clinicaltrials.com.

OCT Business Development team is attending this event. Please contact them at jnedokusheva@oct-clinicaltrials.com.

OCT Business Development team is attending this event. Please contact them at jnedokusheva@oct-clinicaltrials.com.

OCT Business Development team is attending this event. Please contact them at jnedokusheva@oct-clinicaltrials.com.

OCT Business Development team is attending this event. Please contact them at azaichenko@oct-clinicaltrials.com.

OCT Business Development team is attending this event. Please contact them at azaichenko@oct-clinicaltrials.com.

OCT started phase III trial in breast cancer at 11 sites in Russia.

OCT completed enrolment of 1223 patients in 11 sites across Russia in post- marketing study in pulmonology 1 month ahead.

OCT has started a Phase II trial in endometrial cancer in 6 sites in Russia and Estonia. The study is also to be launched in Latvia, Lithuania and Czech Republic later in 2010.

OCT started a device trial in surgery in Baltic States.

OCT started a phase III trial in mastocytosis in 11 sites in Russia, Bulgaria and Latvia.

OCT started collaboration with RUSNANO.

OCT started a phase IV pediatric trial in acute bronchitis in 12 sites in Russia.

OCT signed an exclusive collaboration agreement for providing regulatory support in Russia and Ukraine for a big pharmaceutical company.

OCT completed enrolment in Crohn’s disease trial conducted in 7 sites in Ukraine (3 months, 30 patients).